Table 3.
Summary statistics (2.5, 50, and 97.5% quantiles) and IQR of the posterior odds of the Control and RUTI groups from the in vivo (nv) and augmented trials after adding the optimal size batch of virtual patients, .
| Group | Model | n v | q 0.025 | q 0.5 | q 0.975 | IQR | |
|---|---|---|---|---|---|---|---|
| Control | In vivo only | 75 | 0 | 0.328 | 0.538 | 0.863 | 0.182 | 
| augmented | 25 | 0.331 | 0.544 | 0.876 | 0.184 | ||
| RUTI | In vivo only | 75 | 0 | 0.384 | 0.651 | 1.073 | 0.229 | 
| augmented | 26 | 0.370 | 0.634 | 1.059 | 0.229 | ||
| Ratio | In vivo only | 75 | 0 | 0.592 | 1.210 | 2.456 | 0.592 | 
| augmented | 25 + 26 | 0.565 | 1.162 | 2.355 | 0.580 |